Cash · 2017–2025

Bridgebio Pharma cash

$570M−16.3% · FY2025

Bridgebio Pharma (BBIO) reported $570M in cash for fiscal 2025, −16.3% year on year.

$92.0M2017$436M2018$364M2019$356M2020$394M2021$377M2022$376M2023$681M2024$570M2025
Bridgebio Pharma — Cash, 2017–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$570M−16.3%Open →
FY20242024-12-31$681M+81.2%Open →
FY20232023-12-31$376M−0.2%Open →
FY20222022-12-31$377M−4.3%Open →
FY20212021-12-31$394M+10.6%Open →
FY20202020-12-31$356M−2.1%Open →
FY20192019-12-31$364M−16.6%Open →
FY20182018-12-31$436M+374.0%Open →
FY20172017-12-31$92.0M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +25.6%

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Bridgebio Pharma cash |url=https://companiesranked.com/en/company/bridgebio-pharma/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Bridgebio Pharma cash. CompaniesRanked. https://companiesranked.com/en/company/bridgebio-pharma/cash-on-hand

BibTeX

@misc{companiesranked-en-company-bridgebio-pharma-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Bridgebio Pharma cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/bridgebio-pharma/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001743881-26-000027 · August 10, 2026

{{cite web |title=Bridgebio Pharma cash — 10-Q (0001743881-26-000027) |url=https://www.sec.gov/Archives/edgar/data/1743881/000174388126000027/bbio-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-10}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Bridgebio Pharma overview